(Q71089171)
Statements
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma (English)
Wos E
Olencki T
Tuason L
Budd GT
Peereboom D
Sandstrom K
McLain D
Finke J